Manufacturing-dependent change in biological activity of the TLR4 agonist GSK1795091 and implications for lipid A analog development.

Steeghs N, Hansen AR, Hanna GJ, Garralda E, Park H, Strauss J, Adam M, Campbell G, Carver J, Easton R, Mays K, Skrdla P, Struemper H, Washburn ML, Matheny C, Piha-Paul SA.

Open source

DOI
10.1111/cts.13387
Published
2022-09-12
Container
Clin Transl Sci
Publisher
Not recorded
Open access
yes

Credibility signals

uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1111/cts.13387,
  title = {Manufacturing-dependent change in biological activity of the TLR4 agonist GSK1795091 and implications for lipid A analog development.},
  author = {Steeghs N and  Hansen AR and  Hanna GJ and  Garralda E and  Park H and  Strauss J and  Adam M and  Campbell G and  Carver J and  Easton R and  Mays K and  Skrdla P and  Struemper H and  Washburn ML and  Matheny C and  Piha-Paul SA.},
  year = {2022},
  journal = {Clin Transl Sci},
  doi = {10.1111/cts.13387},
  url = {https://doi.org/10.1111/cts.13387}
}

RIS

TY  - JOUR
TI  - Manufacturing-dependent change in biological activity of the TLR4 agonist GSK1795091 and implications for lipid A analog development.
AU  - Steeghs N
AU  -  Hansen AR
AU  -  Hanna GJ
AU  -  Garralda E
AU  -  Park H
AU  -  Strauss J
AU  -  Adam M
AU  -  Campbell G
AU  -  Carver J
AU  -  Easton R
AU  -  Mays K
AU  -  Skrdla P
AU  -  Struemper H
AU  -  Washburn ML
AU  -  Matheny C
AU  -  Piha-Paul SA.
PY  - 2022
JO  - Clin Transl Sci
DO  - 10.1111/cts.13387
UR  - https://doi.org/10.1111/cts.13387
ER  - 

APA

N, S., AR, H., GJ, H., E, G., H, P., J, S., M, A., G, C., J, C., R, E., K, M., P, S., H, S., ML, W., C, M., & SA., P. (2022). Manufacturing-dependent change in biological activity of the TLR4 agonist GSK1795091 and implications for lipid A analog development.. Clin Transl Sci. https://doi.org/10.1111/cts.13387

Source records